Harrow Health, Inc.
Harrow Health, Inc. (NASDAQ: HROW) is trading at $31.06, about ₹2,983 at today's USD/INR rate, as of 30 Sep 2026, 3:34 PM ET, down 1.10% today. Indian residents can buy Harrow Health from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$30.87
Today's high
$31.86
52 week low
$28.54
52 week high
$54.85
HROW opened at $31.62, closed previously at $31.40, and has traded between $28.54 and $54.85 over the past 52 weeks.
About
Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation. Beyond its direct offerings, Harrow Health maintains equity investments in several pharmaceutical ventures. These encompass Surface Ophthalmics, Inc., a clinical-stage firm actively developing and commercializing therapeutic agents for ocular surface diseases; Melt Pharmaceuticals, Inc., another clinical-stage entity concentrating on proprietary non-intravenous sedation and anesthesia treatments for various medical procedures conducted in hospital, outpatient, and office environments; and Eton Pharmaceuticals, Inc., a commercial-stage company involved in the creation and market launch of drug products. Moreover, Harrow Health holds royalty interests in four investigational drug candidates currently being advanced by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company, initially incorporated in 2006 and based in San Diego, California, underwent a name change from Imprimis Pharmaceuticals, Inc. to Harrow Health, Inc. in December 2018.
Key statistics
Avg. volume
653.44K
Market cap
$1.16B
P/E Ratio
-31.29
Price-to-sales ratio
4.20
Enterprise value
$1.98B
Free cash flow yield
2.37%
Debt-to-equity ratio
19.79
Return on equity
-9.80%
ROIC
12.70%
Beta
0.24
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$272.30M
Earnings per share
-$0.14
Free cash flow
$42.76M
Net profit margin
-13.51%
Gross margin
73.28%
EBITDA
$41.36M
Revenue growth
36.41%
Similar securities
This is not an investment recommendation
How to buy Harrow Health from India
Indian residents can buy Harrow Health shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Harrow Health and place an order
Find Harrow Health by name or by its ticker, HROW, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Harrow Health trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Harrow Health position in USD and INR. Harrow Health pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Harrow Health from India
Trading and taxes when buying Harrow Health from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneHarrow Health does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Harrow Health stock?
Yes. Harrow Health (HROW) has been listed on NASDAQ since 2007, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Harrow Health share cost in rupees?
One Harrow Health share is $31.06 — about ₹2,983 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the Harrow Health price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Harrow Health from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Harrow Health?
Yes. One Harrow Health share is $31.06, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Harrow Health.
How are gains on Harrow Health shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Harrow Health price. Paasa issues a capital-gains statement for your return.
Does Harrow Health pay a dividend?
No. Harrow Health does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Harrow Health from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Harrow Health shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Harrow Health shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Harrow Health holding, its cost and its closing value.
How do I sell Harrow Health and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.